SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001610618-24-000068
Filing Date
2024-05-03
Accepted
2024-05-03 08:00:37
Documents
77
Period of Report
2024-05-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CIDARA THERAPEUTICS, INC. FORM 8-K cdtx-20240503.htm   iXBRL 8-K 27988
2 CORPORATE PRESENTATION, DATED MAY 3, 2024 corporatepresentation202.htm EX-99.1 70191
6 GRAPHIC corporatepresentation202001.jpg GRAPHIC 88225
7 GRAPHIC corporatepresentation202002.jpg GRAPHIC 177347
8 GRAPHIC corporatepresentation202003.jpg GRAPHIC 80739
9 GRAPHIC corporatepresentation202004.jpg GRAPHIC 78317
10 GRAPHIC corporatepresentation202005.jpg GRAPHIC 85704
11 GRAPHIC corporatepresentation202006.jpg GRAPHIC 123231
12 GRAPHIC corporatepresentation202007.jpg GRAPHIC 71952
13 GRAPHIC corporatepresentation202008.jpg GRAPHIC 93307
14 GRAPHIC corporatepresentation202009.jpg GRAPHIC 57971
15 GRAPHIC corporatepresentation202010.jpg GRAPHIC 86150
16 GRAPHIC corporatepresentation202011.jpg GRAPHIC 71660
17 GRAPHIC corporatepresentation202012.jpg GRAPHIC 102712
18 GRAPHIC corporatepresentation202013.jpg GRAPHIC 98471
19 GRAPHIC corporatepresentation202014.jpg GRAPHIC 113275
20 GRAPHIC corporatepresentation202015.jpg GRAPHIC 108041
21 GRAPHIC corporatepresentation202016.jpg GRAPHIC 107197
22 GRAPHIC corporatepresentation202017.jpg GRAPHIC 110118
23 GRAPHIC corporatepresentation202018.jpg GRAPHIC 98413
24 GRAPHIC corporatepresentation202019.jpg GRAPHIC 68457
25 GRAPHIC corporatepresentation202020.jpg GRAPHIC 106682
26 GRAPHIC corporatepresentation202021.jpg GRAPHIC 56276
27 GRAPHIC corporatepresentation202022.jpg GRAPHIC 110991
28 GRAPHIC corporatepresentation202023.jpg GRAPHIC 113134
29 GRAPHIC corporatepresentation202024.jpg GRAPHIC 124738
30 GRAPHIC corporatepresentation202025.jpg GRAPHIC 91856
31 GRAPHIC corporatepresentation202026.jpg GRAPHIC 111743
32 GRAPHIC corporatepresentation202027.jpg GRAPHIC 69213
33 GRAPHIC corporatepresentation202028.jpg GRAPHIC 144975
34 GRAPHIC corporatepresentation202029.jpg GRAPHIC 86081
35 GRAPHIC corporatepresentation202030.jpg GRAPHIC 58443
36 GRAPHIC corporatepresentation202031.jpg GRAPHIC 94358
37 GRAPHIC corporatepresentation202032.jpg GRAPHIC 72210
38 GRAPHIC corporatepresentation202033.jpg GRAPHIC 101201
39 GRAPHIC corporatepresentation202034.jpg GRAPHIC 107749
40 GRAPHIC corporatepresentation202035.jpg GRAPHIC 91310
41 GRAPHIC corporatepresentation202036.jpg GRAPHIC 108454
42 GRAPHIC corporatepresentation202037.jpg GRAPHIC 114972
43 GRAPHIC corporatepresentation202038.jpg GRAPHIC 90354
44 GRAPHIC corporatepresentation202039.jpg GRAPHIC 82312
45 GRAPHIC corporatepresentation202040.jpg GRAPHIC 92796
46 GRAPHIC corporatepresentation202041.jpg GRAPHIC 123544
47 GRAPHIC corporatepresentation202042.jpg GRAPHIC 94603
48 GRAPHIC corporatepresentation202043.jpg GRAPHIC 112438
49 GRAPHIC corporatepresentation202044.jpg GRAPHIC 151713
50 GRAPHIC corporatepresentation202045.jpg GRAPHIC 71279
51 GRAPHIC corporatepresentation202046.jpg GRAPHIC 69191
52 GRAPHIC corporatepresentation202047.jpg GRAPHIC 94032
53 GRAPHIC corporatepresentation202048.jpg GRAPHIC 65779
54 GRAPHIC corporatepresentation202049.jpg GRAPHIC 86618
55 GRAPHIC corporatepresentation202050.jpg GRAPHIC 77182
56 GRAPHIC corporatepresentation202051.jpg GRAPHIC 92305
57 GRAPHIC corporatepresentation202052.jpg GRAPHIC 97819
58 GRAPHIC corporatepresentation202053.jpg GRAPHIC 107403
59 GRAPHIC corporatepresentation202054.jpg GRAPHIC 112368
60 GRAPHIC corporatepresentation202055.jpg GRAPHIC 70453
61 GRAPHIC corporatepresentation202056.jpg GRAPHIC 104166
62 GRAPHIC corporatepresentation202057.jpg GRAPHIC 118483
63 GRAPHIC corporatepresentation202058.jpg GRAPHIC 127826
64 GRAPHIC corporatepresentation202059.jpg GRAPHIC 102193
65 GRAPHIC corporatepresentation202060.jpg GRAPHIC 92511
66 GRAPHIC corporatepresentation202061.jpg GRAPHIC 117305
67 GRAPHIC corporatepresentation202062.jpg GRAPHIC 137558
68 GRAPHIC corporatepresentation202063.jpg GRAPHIC 84954
  Complete submission text file 0001610618-24-000068.txt   8748716

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdtx-20240503.xsd EX-101.SCH 1899
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdtx-20240503_lab.xml EX-101.LAB 22804
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdtx-20240503_pre.xml EX-101.PRE 13048
80 EXTRACTED XBRL INSTANCE DOCUMENT cdtx-20240503_htm.xml XML 2829
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36912 | Film No.: 24910830
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)